case_images: PMC10313222_01
case_images: The structure of HNF1A gene and the patient specific genetic variant: nucleotide 416 in the coding DNA changed from Thymine (T) to Cytosine (C) leading to amino acid change in position 139 in the protein sequence, from Leucine to Proline. E1, Exon1.
case_images: fendo-14-1173471-g001.jpg
case_images: PMC10313222_01_fendo-14-1173471-g001.jpg
case_images: f1
case_images: Leu139Pro),  Figure 1 .
case_images: PMC10313222_02
case_images: The patient's CGM (Libre 2) report in the 2 weeks following insulin discontinuation.
case_images: fendo-14-1173471-g002.jpg
case_images: PMC10313222_02_fendo-14-1173471-g002.jpg
case_images: f2
case_images: Two weeks after the discontinuation of his insulin therapy, his CGM metrics showed a time in range (70-180 mg/dL) of 95%, time above range (181-250 mg/dL) of 4%, and time below range (54-69mg/dL) of 1%,  Figure 2 .
case_images: The patient's timeline from diabetes mellitus diagnosis until today. *Diabetes antibodies: glutamic acid decarboxylase antibodies, anti-insulin antibodies, ant-islet cell antibodies, zinc transporter 8 antibodies. VUS, variant of uncertain significance.
case_images: fendo-14-1173471-g003.jpg
case_images: PMC10313222_02_fendo-14-1173471-g003.jpg
case_images: f3
case_images: He has remained off insulin therapy for 7 months and maintains his glycemia on diet alone.  Figure 3 .